These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 36066963)
21. HMGN5 promotes invasion and migration of colorectal cancer through activating FGF/FGFR pathway. Zhu GJ; Liu F; Xu YG; Zhao CX; Zhao JG; Sun C Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1330-1338. PubMed ID: 33629303 [TBL] [Abstract][Full Text] [Related]
22. Hypoxia-Inducible Factor 1A Upregulates HMGN5 by Increasing the Expression of GATA1 and Plays a Role in Osteosarcoma Metastasis. Xu E; Ji Z; Jiang H; Lin T; Ma J; Zhou X Biomed Res Int; 2019; 2019():5630124. PubMed ID: 31930127 [TBL] [Abstract][Full Text] [Related]
23. High-mobility group nucleosome-binding domain 5 increases drug resistance in osteosarcoma through upregulating autophagy. Yang C; Gao R; Wang J; Yuan W; Wang C; Zhou X Tumour Biol; 2014 Jul; 35(7):6357-63. PubMed ID: 24664583 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice. Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845 [TBL] [Abstract][Full Text] [Related]
25. High mobility group protein N5 (HMGN5) and lamina-associated polypeptide 2α (LAP2α) interact and reciprocally affect their genome-wide chromatin organization. Zhang S; Schones DE; Malicet C; Rochman M; Zhou M; Foisner R; Bustin M J Biol Chem; 2013 Jun; 288(25):18104-9. PubMed ID: 23673662 [TBL] [Abstract][Full Text] [Related]
26. ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer. Liu ZH; Chen ML; Zhang Q; Zhang Y; An X; Luo YL; Liu XM; Liu SX; Liu Q; Yang T; Liu YM; Liu BL; Zhou AJ; Li MZ; Liu YJ; Liu ZX; Zhong Q Int J Cancer; 2020 Jul; 147(2):505-518. PubMed ID: 32064600 [TBL] [Abstract][Full Text] [Related]
27. Hmgn5 functions downstream of Hoxa10 to regulate uterine decidualization in mice. Li DD; Zhao SY; Yang ZQ; Duan CC; Guo CH; Zhang HL; Geng S; Yue ZP; Guo B Cell Cycle; 2016 Oct; 15(20):2792-805. PubMed ID: 27579887 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5. Jiang W; Zheng J; Yu T; Wang J Oncol Rep; 2017 Aug; 38(2):1099-1107. PubMed ID: 28627703 [TBL] [Abstract][Full Text] [Related]
29. [Opposite Effects of Histone H1 and HMGN5 Protein on Distant Interactions in Chromatin]. Nizovtseva EV; Polikanov YS; Kulaeva OI; Clauvelin N; Postnikov YV; Olson WK; Studitsky VM Mol Biol (Mosk); 2019; 53(6):1038-1048. PubMed ID: 31876282 [TBL] [Abstract][Full Text] [Related]
30. Metabolomics reveals a role for the chromatin-binding protein HMGN5 in glutathione metabolism. Ciappio ED; Krausz KW; Rochman M; Furusawa T; Bonzo JA; Tessarollo L; Gonzalez FJ; Bustin M PLoS One; 2014; 9(1):e84583. PubMed ID: 24392144 [TBL] [Abstract][Full Text] [Related]
31. Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo. Ji SQ; Yao L; Zhang XY; Li XS; Zhou LQ J Exp Clin Cancer Res; 2012 Mar; 31(1):22. PubMed ID: 22420896 [TBL] [Abstract][Full Text] [Related]
32. [Growth inhibition of breast cancer cells in vitro and in vivo by siRNA targeting signal transducers and activators of transcription 3]. Yang Z; Yan L; Zhang F; Yan QH; Song WQ; Wang FA; Cai JH Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):819-24. PubMed ID: 21223686 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy. Meng Y; Gao R; Ma J; Zhao J; Xu E; Wang C; Zhou X Sci Rep; 2017 Mar; 7(1):416. PubMed ID: 28341864 [TBL] [Abstract][Full Text] [Related]
34. The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription. Rochman M; Postnikov Y; Correll S; Malicet C; Wincovitch S; Karpova TS; McNally JG; Wu X; Bubunenko NA; Grigoryev S; Bustin M Mol Cell; 2009 Sep; 35(5):642-56. PubMed ID: 19748358 [TBL] [Abstract][Full Text] [Related]
35. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway. Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089 [TBL] [Abstract][Full Text] [Related]
36. LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer. Wang Q; Liu J; You Z; Yin Y; Liu L; Kang Y; Li S; Ning S; Li H; Gong Y; Xu S; Pang D Cell Death Dis; 2021 Jan; 12(1):83. PubMed ID: 33446634 [TBL] [Abstract][Full Text] [Related]
37. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line. Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295 [TBL] [Abstract][Full Text] [Related]
38. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells. Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225 [TBL] [Abstract][Full Text] [Related]
39. HMGN5 expression in bladder cancer tissue and its role on prognosis. Wu J; Wang J Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):970-975. PubMed ID: 29509244 [TBL] [Abstract][Full Text] [Related]
40. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer. Wang L; Kong W; Liu B; Zhang X Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]